Literature DB >> 12911829

Clinical and CT characteristics of Chinese medicine-induced acute respiratory distress syndrome.

Osamu Sakamoto1, Kazuya Ichikado, Hirotsugu Kohrogi, Moritaka Suga.   

Abstract

OBJECTIVE: The aim of the present study was to explore the clinical and radiographic characteristics of Chinese medicine-induced acute respiratory distress syndrome (ARDS), focusing on high resolution CT (HRCT) findings.
METHODOLOGY: Five patients diagnosed with Chinese medicine-induced ARDS were enrolled in the study. Details regarding clinical history, previous medical history, and laboratory data were collected and reviewed. The extent of involvement of each HRCT abnormality was assessed for each of three zones of each lung and was estimated to the nearest 10% of parenchymal involvement.
RESULTS: The causative Chinese medicines were as follows: Sho-saiko-to (two cases), Sai-rei-to (two cases) and Otsu-ji-to (one case). Scutellariae radix was the common ingredient in these drugs. The mean duration of medication use before the onset of ARDS was 22 days (range 7-49 days). High levels of C-reactive protein and lactate dehydrogenase (LDH), and mild liver dysfunction were common laboratory findings. The major HRCT findings were as follows: ground-glass opacity 50.2% (range 37-68%); airspace consolidation 16.0% (7-27%); spared area 26.6% (7-45%). In addition, the abnormalities tended to predominate in the peribronchovascular regions. Furthermore, architectural distortion was seen in all five cases, interlobular septal thickening occurred in four, irregular interface in four, and interlobar effusion in two. Corticosteroid therapy was very effective, and partial pressure of arterial oxygen to fraction of inspired oxygen (PaO2/FIO2) improved in proportion to the decrease in LDH level.
CONCLUSIONS: Patients with Chinese medicine-induced acute lung injury exhibited ARDS. However, their prognosis was satisfactory, which suggests that a hypersensitivity reaction or a permeability oedema with minimal epithelial injury may be involved in the pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12911829     DOI: 10.1046/j.1440-1843.2003.00470.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  5 in total

1.  Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B.

Authors:  De Zhao Kong; Ning Liang; Guan Lin Yang; Zhe Zhang; Yue Liu; Jing Li; Xuehan Liu; Shibing Liang; Dimitrinka Nikolova; Janus C Jakobsen; Christian Gluud; Jian Ping Liu
Journal:  Cochrane Database Syst Rev       Date:  2019-11-07

2.  Patient safety incident reports related to traditional Japanese Kampo medicines: medication errors and adverse drug events in a university hospital for a ten-year period.

Authors:  Yutaka Shimada; Makoto Fujimoto; Tatsuya Nogami; Hidetoshi Watari; Hideyuki Kitahara; Hiroki Misawa; Yoshiyuki Kimbara
Journal:  BMC Complement Altern Med       Date:  2017-12-21       Impact factor: 3.659

3.  The use of Traditional Chinese Medicines to treat SARS-CoV-2 may cause more harm than good.

Authors:  Paul E Gray; Yvonne Belessis
Journal:  Pharmacol Res       Date:  2020-04-03       Impact factor: 7.658

4.  Therapeutic effects of saireito (chai-ling-tang), a traditional Japanese herbal medicine, on lymphedema caused by radiotherapy: a case series study.

Authors:  Aiko Nagai; Yuta Shibamoto; Keiko Ogawa
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-04       Impact factor: 2.629

5.  Application of Scutellariae radix, Gardeniae fructus, and Probiotics to Prevent Salmonella enterica Serovar Choleraesuis Infection in Swine.

Authors:  Chiung-Hung Chang; Yueh-Sheng Chen; Ming-Tang Chiou; Chiu-Hsian Su; Daniel S Chen; Chin-En Tsai; Bi Yu; Yuan-Man Hsu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-26       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.